Synthetic Biology of mRNA

Información del proyecto

NEWmRNA

Identificador del acuerdo de subvención: 965135

DOI

10.3030/965135

Proyecto cerrado

Fecha de la firma de la CE 16 Diciembre 2020

Fecha de inicio 1 Marzo 2021

Fecha de finalización 31 Agosto 2025

Financiado con arreglo a

• EXCELLENT SCIENCE - Future and Emerging Technologies (FET)

Coste total

€ 2 998 545,00

Aportación de la UE

€ 2 998 545,00

Coordinado por

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Switzerland

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (13)

Synthesis of novel nucleoside triphosphates, part I

Report on nonconfidential synthesis of novel nucleoside triphosphates with modified bases focus on pyrimidinelike bases

Partially operative T7 RNAPol variant

Report on nonconfidential aspects of first partially operative T7 RNAPol variants

Synthesis of novel nucleoside triphosphates for in vitro transcription

Report on nonconfidential aspects of synthesis of novel nucleoside triphosphates with noncanonical sugars for in vitro transcription U and Ccarrying bases

Dissemination and exploitation plan
Chemical assembly of short mRNAs, part I

Report on nonconfidential aspects of chemical assembly of short mRNAs

Report on .eu project website and logo

Report on eu project website and logo M2 ETH Zrich

Enzyme with hydrolytic activity for cNMP

Summary report on nonconfidential aspects of enzyme development for deblocking cNMP

CNA precursor uptake

Report on nonconfidential aspects of import engineering for CNA precursors

Robust E. coli chassis lacking phosphoribose and PRPP metabolism

Summary report on nonconfidential aspects of engineering PRPP metabolismfree E coli

Production of circRNA in E. coli (short RNA)

Protocol for efficient production of short circRNA production in E coli

Synthesis of transport and in vivo transcription substrates, part I

Report on nonconfidential aspects of synthesis of transport and in vivo transcription substrates using carbamate cNTPs focus on U and Cbases

Establishment of T7 RNAPol mutant libraries and HTP screen

Report on the establishment of T7 RNAPol mutant libraries and a suitable HTP screen

Characterization of in vivo functionality of oligonucleotides, part I

Preliminary summary report on nonconfidential aspects of the characterization of in vivo functionality of oligonucleotides with noncanonical pyrimidine or purine base moieties

Open Research Data Pilot (1)

Data management plan

Report on data management plan

Publicaciones

Peer reviewed articles (13)

A microbiological system for screening the interference of XNA monomers with DNA and RNA metabolism.

Autores: Blanchard, A., Abramov, M., Hassan, C., Marliere, P., Herdewijn, P., Pezo, V. A
Publicado en: RSC Advances, 2023, ISSN 2046-2069
Editor: Royal Society of Chemistry
DOI: 10.1039/d3ra06172h

In vivo assembly and expression of DNA containing non-canonical bases in the yeast Saccharomyces cerevisiae.

Autores: Nguyen, H., Abramov, M., Rozenski, J., Ermeeva, E., Herdewijn, P.
Publicado en: ChemBioChem, 2023, ISSN 1439-4227
Editor: John Wiley & Sons Ltd.
DOI: 10.1002/cbic.202200060

LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes

Autores: Jennifer Keller, Judit Danis, Isabella Krehl, Eleftheria Girousi, Takashi K. Satoh, Barbara Meier-Schiesser, Lajos Kemény, Márta Széll, W. Wei-Lynn Wong, Steve Pascolo, Lars E. French, Thomas M. Kündig, Mark Mellett
Publicado en: Cell Death & Disease, Edición 16, 2025, ISSN 2041-4889
Editor: Nature Publishing Group
DOI: 10.1038/s41419-025-07537-9

Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo

Autores: Shahab Mamaghani, Rocco Roberto Penna, Julia Frei, Conrad Wyss, Mark Mellett, Thomas Look, Tobias Weiss, Emmanuella Guenova, Thomas M. Kündig, Severin Lauchli, Steve Pascolo
Publicado en: Cells, Edición 13, 2024, Página(s) 1242, ISSN 2073-4409
Editor: MDPI AG
DOI: 10.3390/cells13151242

Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring

Autores: Jarzebska NT, Frei J, Lauchli S, French LE, Guenova E, Gouttefangeas C, Kündig TM, Mellett M, Pascolo S
Publicado en: Viruses, Edición 13, 2021, Página(s) 1232, ISSN 1999-4915
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v13071232

Data-driven protease engineering by DNA-recording and epistasis-aware machine learning

Autores: Lukas Huber, Tim Kucera, Simon Höllerer, Karsten Borgwardt, Sven Panke, Markus Jeschek
Publicado en: Nature Communications, Edición 16, 2025, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-025-60622-7

CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids.

Autores: Yang H, Eremeeva E, Abramov M, Jacquemyn M, Groaz E, Daelemans D, Herdewijn P.
Publicado en: Nucleic Acids Research, 2023, ISSN 0305-1048
Editor: Oxford University Press
DOI: 10.1093/nar/gkac1147

Vaccines against COVID-19: Priority to mRNA-Based Formulations.

Autores: Pascolo S
Publicado en: Cells, Edición 10, 2021, Página(s) 2716, ISSN 2073-4409
Editor: MDPI
DOI: 10.3390/cells10102716

Protamine-Based Strategies for RNA Transfection

Autores: Jarzebska NT, Mellett M, Frei J, Kündig TM, Pascolo S
Publicado en: Pharmaceutics, Edición 13, 2021, Página(s) 877, ISSN 1999-4923
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics13060877

Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history

Autores: Pascolo S
Publicado en: Europ. J. Immun., 2023, ISSN 0014-2980
Editor: John Wiley & Sons Ltd.
DOI: 10.1002/eji.202249941

Differential functionality of fluoropyrimidine nucleosides for safe cancer therapy

Autores: Tim Holzinger, Julia Frei, Natalia Teresa Jarzebska, Hans-Dietmar Beer, Thomas M. Kündig, Steve Pascolo, Severin Läuchli, Mark Mellett
Publicado en: Anti-Cancer Drugs, Edición 35, 2025, Página(s) 912-921, ISSN 0959-4973
Editor: Lippincott Williams & Wilkins Ltd.
DOI: 10.1097/cad.0000000000001644

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Autores: Romano E, Pascolo S, Ott P
Publicado en: J Immunother Cancer, Edición 9, 2021, Página(s) e002932, ISSN 2051-1426
Editor: BMJ
DOI: 10.1136/jitc-2021-002932

Modulation of the tetrameric I-motif folding of C-rich Tetrahymena telomeric sequences by hexitol nucleic acid (HNA) modifications.

Autores: Ghezzo M, Grigoletto L, Rigo R, Herdewijn P, Groaz E, Sissi C.
Publicado en: Biochimie, 2023, ISSN 0300-9084
Editor: Elsevier BV
DOI: 10.1016/j.biochi.2023.08.003